Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval
According to a press release, the gene therapy company bluebird bio, inc. has recently announced that its gene therapy elivaldogene autotemcel (marketed as SKYSONA) has received Accelerated Approval status from…